Athenex (FRA:2MT0) Other Operating Expense : €-0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Athenex Other Operating Expense?

Athenex's Other Operating Expense for the three months ended in Dec. 2022 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.00 Mil.

Athenex's quarterly Other Operating Expense increased from Jun. 2022 (€0.00 Mil) to Sep. 2022 (€0.00 Mil) but then declined from Sep. 2022 (€0.00 Mil) to Dec. 2022 (€-0.00 Mil).

Athenex's annual Other Operating Expense declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€-0.00 Mil) but then increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€0.00 Mil).

Athenex Other Operating Expense Historical Data

The historical data trend for Athenex's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athenex Other Operating Expense Chart

Athenex Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

Athenex Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Athenex Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

Athenex Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Athenex's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Athenex (FRA:2MT0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Athenex Inc (FRA:2MT0) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Main Street, Suite 600, Conventus Building, Buffalo, NY, USA, 14203

Website

https://www.athenex.com

Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting preclinical and clinical testing, recruiting personnel, identifying and evaluating additional drug candidates for potential in-licensing or acquisition, and raising capital to support development and commercialization activities.

Athenex (FRA:2MT0) Headlines

No Headlines